These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 199148)

  • 1. Treatment of hypercholesterolaemia with oral lecithin.
    Simons LA; Hickie JB; Ruys J
    Aust N Z J Med; 1977 Jun; 7(3):262-6. PubMed ID: 199148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U; Johannes KJ
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1127-30. PubMed ID: 184377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
    Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
    Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R; Müller A; Klose G; Middelhoff G; Augustin J; Haase W; Greten H
    MMW Munch Med Wochenschr; 1978 Apr; 120(15):525-8. PubMed ID: 206826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 6. Secholex, Clofibrate and taurine in hyperlipidaemia.
    Howard AN; Evans RJ
    Atherosclerosis; 1974; 20(1):105-16. PubMed ID: 4376405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B (author's transl)].
    Mertz DP; Suermann I; Göhmann E
    MMW Munch Med Wochenschr; 1978 Aug; 120(34):1097-9. PubMed ID: 210375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of lipoprotein pattern by clofibrate in hyperglyceridaemia and mixed hyperlipidaemia.
    Miettinen TA; Penttilä IM; Lampainen E
    Acta Med Scand; 1972 Sep; 192(3):177-82. PubMed ID: 4341290
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
    Hunninghake DB; Bell C; Olson L
    Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
    Evans RJ; Howard AN; Hyams DE
    Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of type III hyperlipoproteinemia with four different treatment regimens.
    Hoogwerf BJ; Bantle JP; Kuba K; Frantz ID; Hunninghake DB
    Atherosclerosis; 1984; 51(2-3):251-9. PubMed ID: 6588975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
    Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
    Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of treatment with a bile-sequestering agent (Secholex) on intestinal absorption, duodenal bile acids, and plasma lipids.
    Ritland S; Fausa O; Gjone E; Blomhoff JP; Skrede S; Lanner A
    Scand J Gastroenterol; 1975; 10(8):791-800. PubMed ID: 173015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
    Crouse JR; Grundy SM
    Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA; Grundy SM
    JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of soya lecithin on serum lipid values in type II hyperlipoproteinemia.
    ter Welle HF; van Gent CM; Dekker W; Willebrands AF
    Acta Med Scand; 1974 Apr; 195(4):267-71. PubMed ID: 4362483
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
    Mordasini R; Riesen W; Oster P; Keller M; Middelhoff G; Lang PD
    Atherosclerosis; 1981 Oct; 40(2):153-8. PubMed ID: 6796096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
    Lehtonen A; Viikari J
    Atherosclerosis; 1979 May; 33(1):49-58. PubMed ID: 223601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.